Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
236
Frequently Asked Questions
What is Market Cap of Metagenomi Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Metagenomi Inc. market cap is $207.93M.
What is the 52-week high for Metagenomi Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Metagenomi Inc. 52 week high is $15.00 as of June 16, 2024.
What is the 52-week low for Metagenomi Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Metagenomi Inc. 52 week low is $5.40 as of June 16, 2024.
What is Metagenomi Inc. stock price today?
Metagenomi Inc. stock price today is $5.55.
What was Metagenomi Inc. stock price yesterday?
Metagenomi Inc. stock price yesterday was $6.00.
What is the Price-to-Book ratio of Metagenomi Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Metagenomi Inc. P/B ratio is 0.7544.
What is the 50-day moving average of Metagenomi Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Metagenomi Inc. 50-day moving average is $7.13.